Healthcare provider profile · identity verified

Caroline Cooper, NP

Nurse Practitioner · NEWARK, NY · NPI 1790296820

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	380	44
Sertraline Hcl	Sertraline Hcl	347	44
Furosemide	Furosemide	307	54
Atorvastatin Calcium	Atorvastatin Calcium	272	48
Potassium Chloride	Potassium Chloride	257	20
Trazodone Hcl	Trazodone Hcl	243	36
Gabapentin	Gabapentin	238	34
Pantoprazole Sodium	Pantoprazole Sodium	233	41
Buspirone Hcl	Buspirone Hcl	225	35
Eliquis	Apixaban	215	42
Omeprazole	Omeprazole	181	32
Tamsulosin Hcl	Tamsulosin Hcl	159	14
Losartan Potassium	Losartan Potassium	142	23
Metoprolol Tartrate	Metoprolol Tartrate	134	24
Amlodipine Besylate	Amlodipine Besylate	125	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	120	24
Lisinopril	Lisinopril	117	22
Metoprolol Succinate	Metoprolol Succinate	107	20
Duloxetine Hcl	Duloxetine Hcl	104	14
Mirtazapine	Mirtazapine	101	22
Prednisone	Prednisone	99	32
Metformin Hcl Er	Metformin Hcl	89	suppressed
Famotidine	Famotidine	85	19
Torsemide	Torsemide	83	17
Metformin Hcl	Metformin Hcl	73	18
Escitalopram Oxalate	Escitalopram Oxalate	72	12
Warfarin Sodium	Warfarin Sodium	67	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	66	15
Alprazolam	Alprazolam	64	suppressed
Divalproex Sodium	Divalproex Sodium	64	suppressed
Donepezil Hcl	Donepezil Hcl	62	suppressed
Carvedilol	Carvedilol	59	12
Methenamine Hippurate	Methenamine Hippurate	59	suppressed
Clopidogrel	Clopidogrel Bisulfate	57	suppressed
Jardiance	Empagliflozin	57	suppressed
Ondansetron Hcl	Ondansetron Hcl	56	23
Rosuvastatin Calcium	Rosuvastatin Calcium	52	suppressed
Fluticasone Propionate	Fluticasone Propionate	50	12
Montelukast Sodium	Montelukast Sodium	49	suppressed
Propranolol Hcl	Propranolol Hcl	48	suppressed
Ropinirole Hcl	Ropinirole Hcl	45	suppressed
Dilt-Xr	Diltiazem Hcl	43	suppressed
Trulicity	Dulaglutide	41	suppressed
Allopurinol	Allopurinol	40	suppressed
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Tramadol Hcl	Tramadol Hcl	39	12
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Morphine Sulfate	Morphine Sulfate	38	15
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Bupropion Xl	Bupropion Hcl	37	suppressed
Finasteride	Finasteride	37	12
Myrbetriq	Mirabegron	36	suppressed
Spironolactone	Spironolactone	35	suppressed
Latanoprost	Latanoprost	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	suppressed
Digoxin	Digoxin	33	suppressed
Levetiracetam	Levetiracetam	33	suppressed
Oxycodone Hcl	Oxycodone Hcl	33	suppressed
Pregabalin	Pregabalin	33	suppressed
Memantine Hcl	Memantine Hcl	30	suppressed
Simvastatin	Simvastatin	30	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	29	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	27	suppressed
Meloxicam	Meloxicam	26	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	25	suppressed
Diazepam	Diazepam	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Lagevrio (Eua)	Molnupiravir	25	25
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	23	11
Diltiazem Hcl	Diltiazem Hcl	23	suppressed
Lorazepam	Lorazepam	23	12
Insulin Lispro Kwikpen U-100	Insulin Lispro	21	suppressed
Raloxifene Hcl	Raloxifene Hcl	21	suppressed
Trospium Chloride	Trospium Chloride	21	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	19	19
Divalproex Sodium Er	Divalproex Sodium	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	17
Bumetanide	Bumetanide	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Ursodiol	Ursodiol	18	suppressed
Veltassa	Patiromer Calcium Sorbitex	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Estradiol	Estradiol	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Fentanyl	Fentanyl	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	14	suppressed
Azithromycin	Azithromycin	14	suppressed
Carbamazepine Er	Carbamazepine	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Linzess	Linaclotide	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	12
Timolol Maleate	Timolol Maleate	14	suppressed
Gemtesa	Vibegron	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Clonazepam	Clonazepam	12	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	12	suppressed
Insulin Aspart Flexpen	Insulin Aspart	12	suppressed
Methimazole	Methimazole	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Vimpat	Lacosamide	12	suppressed
Brinzolamide	Brinzolamide	11	suppressed
Budesonide Dr	Budesonide	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Primidone	Primidone	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error